Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Iacobaeus

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Clinical Medicine|December 8, 2019
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I StudyEllen Iacobaeus, Nadir Kadri, Katia Lefsihane, et al.
Frontiers in Immunology|October 17, 2019
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by MonocytesCaroline Gavin, Stephan Meinke, Nina Heldring, et al.
Plos One|May 17, 2011
The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosisEllen Iacobaeus, Petra Amoudruz, Mikael Ström, et al.
European Journal of Neurology|March 20, 2024
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysisCaroline Hagbohm, Russell Ouellette, Eoin P Flanagan, et al.
Immunology and Cell Biology|March 24, 2018
Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosisEllen Iacobaeus, Iyadh Douagi, Regina Jitschin, et al.
Stem Cells Translational Medicine|September 24, 2017
Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and DemyelinationEllen Iacobaeus, Rachael V Sugars, Anton Törnqvist Andrén, et al.
Journal of Translational Autoimmunity|July 17, 2025
Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosusJulius Lindblom, Guillermo Barturen, Lorenzo Beretta, et al.
Nature Genetics|July 31, 2007
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosisFrida Lundmark, Kristina Duvefelt, Ellen Iacobaeus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2014
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experienceJoachim Burman, Ellen Iacobaeus, Anders Svenningsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2023
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort studyThomas Silfverberg, Christina Zjukovskaja, Per Ljungman, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Clinical Medicine|December 8, 2019
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I StudyEllen Iacobaeus, Nadir Kadri, Katia Lefsihane, et al.
Frontiers in Immunology|October 17, 2019
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by MonocytesCaroline Gavin, Stephan Meinke, Nina Heldring, et al.
Plos One|May 17, 2011
The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosisEllen Iacobaeus, Petra Amoudruz, Mikael Ström, et al.
European Journal of Neurology|March 20, 2024
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysisCaroline Hagbohm, Russell Ouellette, Eoin P Flanagan, et al.
Immunology and Cell Biology|March 24, 2018
Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosisEllen Iacobaeus, Iyadh Douagi, Regina Jitschin, et al.
Stem Cells Translational Medicine|September 24, 2017
Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and DemyelinationEllen Iacobaeus, Rachael V Sugars, Anton Törnqvist Andrén, et al.
Journal of Translational Autoimmunity|July 17, 2025
Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosusJulius Lindblom, Guillermo Barturen, Lorenzo Beretta, et al.
Nature Genetics|July 31, 2007
Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosisFrida Lundmark, Kristina Duvefelt, Ellen Iacobaeus, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 21, 2014
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experienceJoachim Burman, Ellen Iacobaeus, Anders Svenningsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 25, 2023
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort studyThomas Silfverberg, Christina Zjukovskaja, Per Ljungman, et al.
Pageof 4